MDR1 gene expression and drug resistance of AML cells.

Nørgaard, J M; Bukh, A; Langkjer, S T; Clausen, N; Palshof, T; Hokland, P

Nørgaard, J M; Bukh, A; Langkjer, S T; Clausen, N; Palshof, T; Hokland, P.

Affiliation

Nørgaard JM; Department of Medicine and Haematology, Aarhus University Hospital, Denmark.

Br J Haematol ; 100(3): 534-40, 1998 Mar.

Article in En | MEDLINE | ID: mdl-9504636

Subject(s)

Antineoplastic Agents/therapeutic use; Drug Resistance, Neoplasm/genetics; Genes, MDR/genetics; Leukemia, Myeloid/drug therapy; Leukemia, Myeloid/genetics; Aclarubicin/therapeutic use; Acute Disease; Cytarabine/therapeutic use; Daunorubicin/therapeutic use; Doxorubicin/therapeutic use; Etoposide/therapeutic use; Gene Expression; Humans; Lethal Dose 50; Mitoxantrone/therapeutic use; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid / Drug Resistance, Neoplasm / Genes, MDR / Antineoplastic Agents Limits: Humans Language: En Journal: Br J Haematol Year: 1998 Document type: Article Affiliation country: Denmark Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links